Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$91,535,352
+$74,737,503 QoQ
Shares Held
3,801,302
+535.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#105
of 2,821 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. PFE ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
This page
|
3,801,302 | $91,535,352 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,535,352 | 3,801,302 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,797,849 | 598,214 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $59,924,165 | 2,406,593 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $96,518,061 | 3,787,993 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $120,236,605 | 4,960,256 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,134,331 | 2,491,489 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,204,620 | 2,382,383 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,050,123 | 1,660,336 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $49,922,923 | 1,784,236 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,386,735 | 1,599,522 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $115,251,811 | 4,003,189 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $157,214,920 | 4,739,672 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,772,148 | 3,374,377 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $136,997,668 | 3,357,786 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $231,357,669 | 4,515,177 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $210,456,762 | 4,809,341 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $285,198,280 | 5,439,601 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $342,075,503 | 6,607,601 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $438,948,234 | 7,433,501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $247,698,934 | 5,759,101 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $15,499,230 | 427,801 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $60,926,735 | 1,863,201 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $213,494,066 | 6,540,881 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||